Canaccord lowered the firm’s price target on Life360 (LIF) to $72 from $94 and keeps a Buy rating on the shares. The firm said delivered a generally solid Q1 print, with revenue and adj. EBITDA both ahead of consensus, though MAUs came in approximately 1% light versus consensus as technical issues during the peak Q1 marketing window suppressed new registrations.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LIF: